Wolverine Trading
VSEEW

Wolverine Trading’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History

Wolverine Trading’s Portfolio VSEEW Stock Details VSEEW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,194
Closed -$2K – 5092
2022
Q4 		$2K Buy
+18,194
New +$1.92K ﹤0.01% 3845

Other funds holding VSEEW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Wolverine Trading's VSEEW Position: Q1 2023 in Review

Wolverine Trading sold out of VSEE HEALTH INC WTS 29 (VSEEW) in Q1 2023, closing a stake of 18,194 shares — an estimated $2K sold.

Wolverine Trading first reported a position in VSEEW in Q4 2022 and held it in 1 quarter. The position peaked at $2K in Q4 2022. 31 funds tracked by Wall St. Rank hold VSEEW as of Q1 2023.

  • Wolverine Trading reported no remaining VSEE HEALTH INC WTS 29 position as of Q1 2023 after selling out during the quarter.
  • Wolverine Trading sold 18,194 VSEE HEALTH INC WTS 29 shares in Q1 2023, an estimated $2K.
  • Wolverine Trading first reported a position in VSEE HEALTH INC WTS 29 in Q4 2022 and held it in 1 quarter.
  • Wolverine Trading's VSEE HEALTH INC WTS 29 position peaked at $2K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q1 2023.

Based on Wolverine Trading's 13F filing for Q1 2023, filed 15 May 2023.